Corbacioglu Esmer Aytul, Kalelioglu Ibrahim, Keyif Betul, Ozsurmeli Mehmet, Yüksel Atıl, Has Recep
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Istanbul Faculty of Medicine, Istanbul University, Fatih, 34093, Istanbul, Turkey.
J Med Ultrason (2001). 2014 Jan;41(1):51-6. doi: 10.1007/s10396-013-0464-1. Epub 2013 Jun 19.
The objective of this study was to investigate perinatal outcome in cases of increased nuchal translucency (NT) with or without cystic hygroma (CH), and to determine whether first-trimester CH engenders a greater risk than simple increased NT.
In this retrospective study, data from singleton pregnancies in which fetal NT was found to be 3 mm or more at the 11 + 0 to 13 + 6 weeks scan were reviewed. Cases were classified into two groups, namely 'CH' and 'increased NT'.
Of the 76 cases with increased NT, 30 (39.4 %) presented with CH. NT measurement was significantly higher in the CH group (7.25 vs. 3.5 mm, p < 0.001). Abnormal fetal karyotype, major chromosomal anomalies in chromosomally normal fetuses, and adverse outcome were significantly more frequent in the CH group as compared with the increased NT group (p = 0.019, p = 0.021, and p = 0.001, respectively). Regression analysis revealed that NT thickness was the only significant variable in the prediction of chromosomal defect and/or major congenital anomaly (OR 2.05, 95 % CI 1.23-3.42, p = 0.005).
Cystic hygroma results in poorer outcome due to higher NT measurement, and the thickness of NT rather than the presence of septa should be the mainstay of prenatal counseling in cases of increased NT in the first trimester.
本研究的目的是调查伴有或不伴有囊性水瘤(CH)的颈部半透明层(NT)增厚病例的围产期结局,并确定孕早期CH是否比单纯NT增厚带来更大风险。
在这项回顾性研究中,对在孕11⁺⁰至13⁺⁶周超声检查时发现胎儿NT为3毫米或以上的单胎妊娠数据进行了回顾。病例分为两组,即“CH组”和“NT增厚组”。
在76例NT增厚病例中,30例(39.4%)伴有CH。CH组的NT测量值显著更高(7.25对3.5毫米,p<0.001)。与NT增厚组相比,CH组胎儿核型异常、染色体正常胎儿的主要染色体异常以及不良结局的发生率显著更高(分别为p=0.019、p=0.021和p=0.001)。回归分析显示,NT厚度是预测染色体缺陷和/或主要先天性异常的唯一显著变量(OR 2.05,95%CI 1.23 - 3.42,p=0.005)。
由于NT测量值更高,囊性水瘤导致的结局更差,对于孕早期NT增厚的病例,NT厚度而非隔膜的存在应成为产前咨询的主要依据。